13958-91-3 Usage
Uses
Used in Pharmaceutical Synthesis:
3,5-Dibromopyridine-4-carboxylic acid is used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into the molecular structures of various drugs. Its unique structure allows for the development of new therapeutic agents with potential applications in treating different diseases.
Used in Agrochemical Production:
In the agrochemical industry, 3,5-Dibromopyridine-4-carboxylic acid is used as a key component in the production of pesticides and other crop protection agents. Its chemical properties make it suitable for creating compounds that can effectively control pests and diseases in agriculture.
Used in Organic Synthesis:
3,5-Dibromopyridine-4-carboxylic acid is utilized as a building block in organic synthesis, contributing to the creation of a wide range of organic compounds. Its reactivity and structural features are valuable for the development of new organic molecules with various applications in different industries.
Safety Precautions:
It is crucial to handle and store 3,5-Dibromopyridine-4-carboxylic acid with care due to its corrosive nature. Proper safety measures should be taken to prevent skin and eye irritation, ensuring that the compound does not come into direct contact with these sensitive areas.
Check Digit Verification of cas no
The CAS Registry Mumber 13958-91-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,5 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13958-91:
(7*1)+(6*3)+(5*9)+(4*5)+(3*8)+(2*9)+(1*1)=133
133 % 10 = 3
So 13958-91-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Br2NO2/c7-3-1-9-2-4(8)5(3)6(10)11/h1-2H,(H,10,11)
13958-91-3Relevant articles and documents
Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: Synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides
Palani, Anandan,Shapiro, Sherry,Clader, John W.,Greenlee, William J.,Vice, Susan,McCombie, Stuart,Cox, Kathleen,Strizki, Julie,Baroudy, Bahige M.
, p. 709 - 712 (2007/10/03)
The synthesis, SAR and biological evaluation of symmetrical amide analogues of our clinical candidate SCH 351125 are described. A series of potent and orally bioavailable CCR5 antagonists containing symmetrical 2,6-dimethyl isonicotinamides and 2, 6-dimethyl pyrimidines amides were generated with enhanced affinity for the CCR5 receptor.
Synthesis of 4-alkyl-3,5-dibromo-, 3-bromo-4,5-dialkyl- and 3,4,5-trialkylpyridines via sequential metalation and metal-halogen exchange of 3,5-dibromopyridine
Gu,Bayburt
, p. 2565 - 2568 (2007/10/03)
Lithiation of 3,5-dibromopyridine with LDA and subsequent reaction with electrophiles provided 4-alkyl-3,5-dibromopyridines 2 in high yield. 3-Bromo-4,5-dialkylpyridines 3 were synthesized by metal-halogen exchange of 2 with one equivalent n-BuLi and reaction with a second electrophile. Further metal-halogen exchange of 3 and reaction with a third electrophile provided 3,4,5-trisubstituted pyridines 4.